Drug spend in hospital environments runs through purchasing, pharmacy, billing, and finance — each with a partial view of what's happening. VativoRx brings a unified rebate process across inpatient and outpatient settings without requiring any of those teams to change how they operate.
Schedule a Discovery Call →Hospitals don't have a rebate problem. They have a coordination problem. Inpatient pharmacy, outpatient clinics, GPO contracts, 340B eligibility, and billing workflows each carry different rules and different stakeholders.
When rebate activity is reviewed, it often happens in pieces — by department, by claim type, by vendor — rather than as a unified picture. The result is inconsistent visibility across the organization and a harder time explaining rebate performance to finance and compliance leadership.
Most hospital finance teams can't tell you what their rebate picture looks like. Not because the data doesn't exist — because no single process is connecting it.
For an acute care health system with no prior rebate management process in place, the first structured review established a baseline picture of eligibility across both inpatient and outpatient drug spend — for the first time.
The engagement identified a meaningful volume of rebate-eligible claims across specialty and acute care therapies that had not previously been captured through existing vendor relationships or billing workflows.
VativoRx connects those environments under a single structured review process — one that covers inpatient and outpatient drug spend together, accounts for GPO and 340B structures from the start, and produces reporting each functional team can use without a custom request.
From first conversation to a clear picture of your drug spend — without disrupting a single team or workflow.
Most health system engagements reach Phase 1 analysis within 1–2 weeks of initial data transfer.